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Abstract
Background—The management of genitourinary malignancies requires a multidisciplinary care
team composed of urologists, medical oncologists and radiation oncologists. A genitourinary (GU)
oncology clinical database is an invaluable resource for patient care and research. Although
electronic medical records provide a single web-based record used for clinical care, billing and
scheduling, information is typically stored in a discipline-specific manner and data extraction is
often not applicable to a research setting. A GU oncology database may be used for the
development of multidisciplinary treatment plans, analysis of disease-specific practice patterns,
and identification of patients for research studies. Despite the potential utility, there are many
important considerations that must be addressed when developing and implementing a discipline-
specific database.
Methods and Materials—The creation of the GU oncology database including prostate,
bladder and kidney cancers with the identification of necessary variables was facilitated by
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meetings of stakeholders in medical oncology, urology, and radiation oncology at the University
of North Carolina (UNC) at Chapel Hill with a template data dictionary provided by the
Department of Urologic Surgery at Vanderbilt University Medical Center. Utilizing Research
Electronic Data Capture (REDCap, version 4.14.5), the UNC Genitourinary OncoLogy Database
(UNC GOLD) was designed and implemented.
Results—The process of designing and implementing a discipline-specific clinical database
requires many important considerations. The primary consideration is determining the relationship
between the database and the Institutional Review Board (IRB) given the potential applications for
both clinical and research uses. Several other necessary steps include ensuring information
technology security and federal regulation compliance; determination of a core complete data set;
creation of standard operating procedures; standardizing entry of free text fields; use of data
exports, queries, and de-identification strategies; inclusion of individual investigators’ data; and
strategies for prioritizing specific projects and data entry.
Conclusions—A discipline-specific database requires a buy-in from all stakeholders,
meticulous development, and data entry resources in order to generate a unique platform for
housing information that may be used for clinical care and research with IRB approval. The steps
and issues identified in the development of UNC GOLD provide a process map for others
interested in developing a GU oncology database.
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INTRODUCTION
Clinical databases are an integral part of patient care and research, providing a clear format
for reviewing both aggregate and individual patient information. To date, utilization of
medical databases has included translational bioinformatics [1], tissue banks [2], quality
control and monitoring [3], as well as others. Although databases are associated with many
advantages, their development and implementation may be challenging. For this reason, we
describe the successful initiation, design, and execution of the University of North Carolina
Genitourinary OncoLogy Database (UNC GOLD), in order to provide others with a process
map (Figure 1).
The electronic medical record (EMR) provides a single web-based patient record, which has
become an invaluable component of modern clinical care. Unfortunately, its potential use as
a research tool is hampered by difficulty extracting data efficiently and in a format that is
applicable to the research setting [4,5]. The capacity for medical records to be accessible
over the internet allows for greater data portability [6], however, because they are so large,
and their uses so diverse, they lack many options for discipline-specific customization.
Furthermore, EMRs are designed to provide a patient-specific picture for clinical care,
billing, and scheduling. While this is practical in a clinic setting, the narrative organizational
structure does not allow querying of data across multiple patients, outputs information in
only a limited number of formats, and lacks options for de-identification [7]. Furthermore,
EMRs often heterogeneously capture treatment mapping, functional status, clinical stages, or
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other relevant factors that may be used during routine care, despite their patient-based
approach. Finally, while access to clinic notes from the entire hospital system may provide
interdisciplinary insights, there is often limited information from referring physicians for
discipline-specific care, especially with respect to patients seen outside of the hospital
system. Because of the complex nature of genitourinary malignancies, a multidisciplinary
team of urologists, medical oncologists, and radiation oncologists share in the care of
patients. This leads to patient information stored in a discipline-centered manner with
limited ability to integrate and analyze the information originating from different providers.
A disease group-specific clinical database may help to compensate for the limitations of the
electronic medical record as well as provide a more readily-accessible means of analyzing
patient data [8]. The clinical database may be used to generate patient lists for tumor board
meetings, analyze disease-specific practice patterns, and identify patients for clinical trials
and other correlative or translational research studies. It may also help to determine the
feasibility of conducting clinical trials in a specific patient population. Furthermore, the
prospective completion of disease-specific data entry forms at predetermined time points can
track disease progression, survival, and other outcomes while avoiding issues such as recall
bias. Finally, the availability of these data to researchers within the disease group offers an
invaluable resource for the conception and development of research projects with IRB
approval.
DATABASE PLANNING AND IMPLEMENTATION
Planning and Input
Although there are clear advantages to clinical databases, the vast amount of information to
be collected renders database development and upkeep a substantial undertaking. For this
reason, cooperation from members of the disease group team is crucial [9]. A buy-in from
these stakeholders in the form of providing input related to the important data points for
each subspecialty increases the robustness of the database and promotes continued data
quality over time. In the development of the current database, UNC GOLD members with
leadership roles in this project (Steering Committee) conferred with other stakeholders
including urologists, radiation oncologists, and medical oncologists at the University of
North Carolina at Chapel Hill to gather input on what information to collect. Three disease-
specific meetings for prostate, kidney and bladder cancer were held to determine the group
and individual goals for the database and to review the necessary data points. This feedback
was then integrated into a genitourinary oncology database backbone provided by colleagues
at Vanderbilt University (D.A.B., C.Y.).
In addition to individual physician involvement, it was necessary to review the literature
regarding clinical databases in general and those specifically designed for kidney, prostate,
and bladder cancer. To that end, PubMed literature searches for “clinical database,”
“REDCap,” “urology database,” and “oncology database” were performed. Articles
specifically discussing databases (as opposed to those citing the database as a data source)
were selected for evaluation. Citations within those articles were also reviewed. This
research yielded recommendations from relevant organizations regarding the variables to
include and specifications about how to record this information [10]. There was also a
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wealth of information discussing the merits of a variety of specific database programs in a
clinical context [11,12].
These publications were beneficial in outlining some of the specific concerns that
accompany clinical databases. Specifically, Smith et al. discuss the importance of
developing a strong but flexible data dictionary and presenting a variety of design
considerations to ease data entry [13]. Others have reported on the necessity of ensuring the
quality and security of database data and methodologies for doing so [14]. Finally,
discussions of information technology considerations [15], and other factors [16,17] in the
literature enabled the UNC GOLD group to successfully integrate the developing database
into existing infrastructure and navigate issues associated with web-based database
platforms.
Database Features
There were several features that the UNC GOLD team identified as critical (Table 1). The
most important feature was compliance with the university data security policy for patient
data. Additionally, it was necessary that both the initial setup as well as the routine data
entry were efficient, error-free, and customizable. Because many of the data points were
defined by stakeholders, the database had to be flexible with respect to both the type and
number of fields. Additionally, since UNC GOLD’s goal is to capture baseline data for
every patient seen in the clinic, as well as periodic updates, it was critical to have a
mechanism to reduce opportunities for data entry errors. Research Electronic Data Capture
(REDCap) [17,18] is fast to navigate, allows for the use of branching logic to hide fields that
are unused for a given patient (e.g. prostate cancer forms for female patients), and runs real-
time validation to ensure that the type of information entered is correct within user-defined
limits (e.g. verifies that all zip codes have 5 numbers and no letters). Within REDCap,
another way to verify data consistency is through the use of “required” fields. When these
fields are not completed, data entry personnel are given an error message and asked to
provide a response so that a minimum dataset is available for all patients. Finally, one of
REDCap’s greatest merits is the speed with which a database can be built; development does
not require any programming knowledge or special training, but forms can be created in a
matter of minutes. Thus, REDCap (current version, 4.14.5) was selected as the platform for
UNC GOLD.
Database Setup
Starting with the template in use at Vanderbilt University, the data fields from the
stakeholders and recommendations from the literature were integrated. This preliminary
version was then modified by the addition of extensive branching logic. Because the UNC
GOLD database includes bladder, ureter, renal pelvis, kidney, and prostate cancers,
branching logic allowed data entry personnel to select only the applicable primary cancer
site, while hiding those remaining, thus avoiding any unwarranted data entry. This
modification also provided for a more streamlined, universal demographics page and
condensed large pages of possible fields to shorter forms that would automatically show
only the relevant fields. With respect to flexibility, UNC GOLD was developed to account
for cases in which a patient develops a second genitourinary primary malignancy, or a tumor
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believed to originate from one site is determined to have a different primary (e.g. a kidney
tumor derived from an upper tract urothelial primary).
Development, Database Structure, and Modification
As the development progressed, it became evident that due to the desired data points such as
progression of disease and survival outcomes, entry would need to occur at multiple time
points. To capture this information, it was necessary to institute a longitudinal data
collection model. REDCap has this capacity, thus the only change was to consider whether
individual forms should be made available at all, or only some, time points. Although
similar databases specify preoperative, operative, and postoperative dates, consideration of
the possibility for treatment variability in these malignancies ultimately led UNC GOLD to
simply number “visits” (dates when the EMR was abstracted). For example, because many
patients do not ultimately undergo surgical intervention as primary therapy, surgically-
defined forms may fail to collect information about other therapies. Additionally, for cases
that require more than one surgery, there are also several preoperative and postoperative
periods. Therefore, rather than disabling forms, information may be entered at any time
point. This setup allows for the potential for multiple operative procedures. To further
increase the capacity of the database, forms for questionnaires relevant to each cancer were
also created.
To ensure the accuracy of UNC GOLD, the database coordinators and Steering Committee
met regularly to discuss possible modifications. Because of the growing size of the project,
and the large number of data entry spaces, the team also defined a core complete set of
variables that would be generally applicable in the context of both clinical quality
improvement, as well as potential research projects (Table 2). By defining this set, the
number of individual data points to enter was reduced, but still captured the information
deemed highest priority. Rather than eliminating the fields that were not on this list,
database coordinators annotated the database by marking those fields that were core
complete. Retaining the unmarked fields was done both to give the database the capacity to
grow over time, as well as to provide the structure for smaller projects looking at those
particular variables.
Standardization of User-Defined Fields
To account for individual differences while maintaining a database that could be queried for
relevant variables, the UNC GOLD team instituted methodologies to standardize the entry of
information into user-defined text boxes. By keeping a list of all “other” entries which may
be copied and pasted as needed, data abstraction personnel verify that information is entered
in a consistent manner. Copying and pasting this information directly out of the “other”
entry list reduces the likelihood of typos while also avoiding multiple records referring to
the same finding with different terminology, for example “kidney stones,” “renal calculi,”
and “nephrolithiasis.” Standardizing in this manner limits the number of queries to a single
term.
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Once UNC GOLD had been created and refined, it was necessary to ensure that data defined
by the stakeholders was available in the medical record, and able to be accurately recorded.
To do this, the database was piloted using a small set of patients with each malignancy
identified from existing Institutional Review Board (IRB) approved clinical databases.
These records were each abstracted by UNC GOLD personnel and compared to the data
contained within the existing databases. This process illustrated several technical glitches
(since rectified) and allowed for analysis of abstraction methodologies. Furthermore, several
disconnects regarding the availability of some of the data points were identified. In some
cases, the hospital or clinic notes did not consistently report specific variables, including
smoking status and the extent of lymph node dissection. Additionally, it was noted that
many older records did not contain information about intraoperative fluids or surgery start
and stop times. Because this information is readily available intra-operatively, a form to
prospectively collect this information specifically for UNC GOLD was created. This form
included all of the operative questions, and could be filled out manually by a surgeon. To
further ease the integration of this surgical data and to reduce the amount of time spent on
each chart abstraction, options for direct data entry were evaluated. One option included
Teleform, (Cardiff Software, Hewlett Packard, Palo Alto, CA) a service that reads scanned
forms and generates raw data that can then be imported into REDCap. Although this feature
could directly read the paper forms, it raised several concerns regarding data quality and
security. Another alternative that was discussed was the use of the integrated REDCap
Survey Tool. This feature allowed specific fields from UNC GOLD to be compiled and
emailed as a survey to the surgeon, rather than as a paper questionnaire. The provider could
complete the form online for each patient treated, using the same data security as the
database, and the data would automatically populate database fields as if a data entry person
had abstracted the information. One limitation of this methodology was the restriction that
each database could only be connected to a single survey; a problem for a database
encompassing several malignancies with distinct surgical treatments.
Production Mode
Because database development allows for the creation and deletion of fields, it is possible to
unintentionally delete or overwrite data. To mitigate that problem, UNC GOLD has been put
into “production mode” wherein modifications to the database structure may not be made by
UNC GOLD personnel. Instead, all proposed changes are provided to the UNC Clinical
Data Manager (C.W.P.) who updates the database and verifies that all data are retained.
ISSUES IDENTIFIED
Although database creation is associated with technical hurdles, more substantive
considerations may also be revealed in the process. These matters require careful attention
prior to data entry. Because clinical databases do not follow the same well-defined set of
requirements as research studies or hospital-level electronic medical records, it is necessary
to search a variety of resources and policies to ensure compliance.
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Regulatory Considerations and Project Prioritization
One of the first issues to be addressed was the involvement of the IRB in the project.
Although the database was created to store clinical information, it may also serve as a
primary data source for research projects. In its capacity as a clinical storehouse, the IRB
does not consider UNC GOLD to be research, and no specific approvals are required for its
creation or for abstraction of patient records. However, if information contained within the
database is used for research purposes, IRB protocol submission and approval are required
(although in many cases these submissions qualify for a waiver of informed consent). In
some cases, physicians requesting de-identified data are exempt from IRB approval,
however, it is the policy of the UNC GOLD group that all studies using this data apply for
IRB approval as part of the data request process (Figure 2). Additionally, because the
research requires review of the medical records, querying of data, and exporting data to
researchers, all IRB applications must include UNC GOLD staff members working with
these data. To simplify the process, researchers requesting access to data must complete a
data request form, which specifies the desired forms or variables. This request is then
reviewed against the IRB protocol to ensure appropriate approval. Once appropriate IRB
approval or exemption has been established, the proposed project is reviewed by the UNC
GOLD Project Review Committee. This committee is composed of individual users of the
database and has a rotating membership roster. The committee determines the priority of
each research project based on the status of ongoing projects as well as available resources.
Finally, database coordinators query the database for the exact information listed on the
request form. In order to maintain the integrity of UNC GOLD, individual investigators do
not receive access to the database or the primary data therein. Instead, only Steering
Committee members and the database coordinators have access to the primary data, and the
coordinators generate reports specific to the data that has been requested. REDCap contains
features to randomly shift dates while maintaining the time between the dates within an
individual record, as well as an option to remove fields marked as identifiers. In addition to
verifying the completeness, accuracy, and regulatory compliance of all data queries, the data
request form also provides a record for auditing purposes.
Information Security Compliance
Similar to determining the relationship between the department’s database and the IRB,
compliance with the institutional data security policy as well as the FDA’s regulations on
electronic records [19] is critical. Although REDCap is designed to be in accord with
national research and clinical standards so as to address federal regulations, UNC has
additional password and access requirements. Particularly with clinical databases that
contain identifiable information and for which patients have not provided consent, it is
important to verify that all aspects of data security are regularly monitored and compared
against any relevant information security policies. It is also the duty of all involved with the
database to use the same precautions as they would for the EMR when reviewing any
information from REDCap. At UNC, the system Clinical Data Manager is responsible for
the day-to-day compliance monitoring.
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Funding for a database is critical to support data management and abstraction staff as well as
IT resources including server space. Possible funding mechanisms include institutional,
cancer center, or department support; grant funding; philanthropy; or industry sponsorship.
The UNC GOLD project is supported by departmental resources.
External Data Sources
Apart from regulatory matters, there are considerations regarding the data itself.
Specifically, information on cause and date of death is very limited in the EMR. Because a
large component of a clinical database involves the tracking of outcomes and survival, it is
important to have high quality information. To supplement the medical record, while still
maintaining a clinical database that does not require IRB approval, it is necessary to acquire
this information from a publically available source. As an example, the North Carolina State
Center for Health Statistics provides vital record information that is available to anyone and
can provide a report of deaths in the state. Another possible source of this data is the Social
Security Death Index (SSDI).
Independent Provider Databases
Another major point of interest in developing UNC GOLD is the ability to integrate IRB
approved patient databases that have been created and maintained by individual providers.
Although these databases do not include the entire core complete dataset, they are a
significant resource for retrospective analyses. Additionally, because that data has heretofore
been limited to a single physician, inclusion of that data into UNC GOLD with IRB
approval allows for greater data sharing and larger patient populations. Despite these
advantages, it is important to note that these records are often antiquated in their formatting,
limited in scope to the specific interests of a single provider, and may not have undergone
data entry and cleaning with the level of rigor of data entered prospectively into the disease
group database. For that reason, identifying and separating the retrospective data from
prospective data (in this case by patient ID numbers) is essential. Review of the data,
formatting for upload to REDCap, and supplementation of retrospective records with
information from the EMR to fulfill the core complete dataset may be utilized to improve
the quality of these resources.
DATA ENTRY
After responding to the issues arising out of database creation, it is necessary to devise
methods for prospective data collection. Principal in this endeavor is the prioritization of
patients for entry into the database. Although the goal is to ultimately capture the entire
clinic population, initially this is not feasible. One option is to limit data collection to
patients with a specific primary cancer site. Alternatively, it is possible to begin data entry
with all new patients seen in clinic. Due to time and resource limitations, the initial goal
selected is prospective data collection for new patients seen in clinic after the date that the
database “went live.” This restriction helps to standardize the way in which data is collected
and reported by reducing the amount of older or archived records, which may be
unavailable. After their initial abstraction, all records in UNC GOLD are updated
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biannually. This length of time was chosen to limit the redundancy of information entered
for patients seen frequently (e.g. patients regularly receiving weekly systemic
chemotherapy), while still capturing information for people with longer follow-up
schedules.
Development of Standard Operating Procedures
In addition to setting the frequency of abstraction and updating, it is important to outline
standard operating procedures (SOPs) for data collection. These SOPs indicate where
information for each field may be found within the medical record, provide clarification
about staging and procedures, and define dummy dates for cases in which a specific date is
unavailable. Additionally, the operating procedures provide guidance with respect to
recording information listed inconsistently in the medical record. All SOPs are updated
regularly based on physician input and issues identified during abstraction.
Data Quality and Staff Abstraction Training
Referring to the SOPs, the database coordinators began record abstraction. Once each had
reviewed and input information from 10–20 patients, the other coordinator then reviewed the
same medical records, noting discrepancies or questions. This check was critical in
identifying fields requiring more explanation, making staff members comfortable with
record abstraction, and providing insight into the inter-rater reliability and data quality that
could be expected from UNC GOLD. Notably, this process illustrated several fields for
which coordinators had different responses supported by information in the medical record.
Discussing among themselves and with relevant clinicians, these conflicts were resolved,
and explanations appended to the abstraction protocol for future reference. This continued
until over 50 patients representing the three genitourinary sites, all treatment modalities, and
a variety of stages had been abstracted.
Duplicate data entry represents a significant resource burden [20]. Because error rates from
the initial 50 patients were low, rather than reviewing each record, bulk data exports are
periodically analyzed for any aberrant, missing, or otherwise problematic data according to
guidelines in the literature [21]. Using this methodology, all records containing a possible
error are reviewed, and changes made if necessary. Data are monitored and cleaned in this
fashion immediately prior to any analysis.
Retrieving, Querying, and Exporting Data
After ensuring sufficient data quality, it was necessary to consider strategies for pulling
project-specific and user-defined datasets. REDCap includes two strategies for compiling
data for analysis: reports and exports. Queries to generate reports may be designed with
fields in any order that the user defines. These queries provide data for view within REDCap
prior to downloading to Microsoft Excel (Microsoft Corporation, Redmond, WA) and can
be saved and reused. Alternatively, exports allow specification of data at the field, form, and
database level, but the ordering of the data maps exactly to that within the database. Exports
also allow for downloading of data in a format compatible with Microsoft Excel as well as a
variety of statistical software packages, with additional options for removing identifiers and
shifting dates within records to comply with date de-identification. Typically, reports and
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queries are more useful for data monitoring tasks such as verifying the absence of duplicated
records, while the de-identification features in the export tool better meet the needs of
researchers requesting data.
Rules for Dissemination of UNC GOLD Related Research
UNC GOLD may be used to support individual research and group projects. In the case of
these larger, collaborative group projects, no individual may publish results, design future,
apply for a patent, or otherwise use data or information from UNC GOLD without the prior
authorization of the Project Review Committee. For collaborative projects, the Project
Review Committee working with members of the specific group is tasked with determining
primary and corresponding authors in such a manner to foster continued collaboration.
Finally, all individual and group investigations should acknowledge UNC GOLD in related
publications.
CONCLUSION
The development of a genitourinary clinical database within a large research institution
provides substantial benefit to clinical and research goals. This project, however, requires a
significant buy-in from all stakeholders, careful development, consideration of a variety of
regulatory and technical issues, and support for ongoing abstraction, updating, and data
cleaning. Although UNC GOLD represents a widely-applicable case study in this process,
individual departments and institutions must consider their own needs.
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Database development process map
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Data request and release
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Table 1
Critical Database Features
Feature Research Electronic Data Capture (REDCap)
Turn-around time Database development time dependent on amount of information to collect and amount of branching
logic necessary; single form creation and set up time <30 minutes in most cases
Ease of use User-friendly interface for both design and data entry
Flexibility Completely user-defined database, within calculation and logical limits of program
Speed Fast; dependent on server and amount of branching logic on page
Availability Supported by the NC TraCS Institute19 at UNC-Chapel Hill
Ease of customization All fields and logic user-defined; specific special fields/calculations available; user interface standard
Data entry & data validation
options
Branching logic hides fields that should be blank; specifications for data format/type; set ranges for date
and numeric fields; double data entry options; definition of “required” fields
Linkage to other databases in
health care system
Currently, no linkage is available
Querying User-defined queries at both form- and field-level available; options to remove identifiers and shift date;
real-time results
Data importing and exporting Available for use with Excel, SAS, STATA, SPSS, and R statistical software packages
Security Compliant with UNC data security and HIPAA requirements
User access rights Can be defined for individuals or sites to prevent unauthorized viewing and editing of data
Additional features Scheduling; option for multiple arms; option for longitudinal structure; file dropbox; integrated survey
tool; data imports
NC TraCS: North Carolina Translational & Clinical Sciences Institute
UNC: University of North Carolina
HIPAA: Health Insurance Portability and Accountability Act
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Table 2
Selected UNC GOLD forms with variables
Preoperative - Bladder Ureter
and Renal Pelvis
Operative – Kidney Pathology - Prostate
When was bladder cancer initially diagnosed?
Referring physician last name
Referring physician first name
Prior Pelvic Radiation?
Prior Abdominal/Pelvic Surgery?
Has patient had a TURBTa or biopsy?
Date of TURBT/biopsy leading to current treatment











Lymphovascular invasion on pathology
Did patient have a restaging TURBT (within 3
months)?
Did pathology change?
What is new pathology?









How many induction courses has patient had?
Preop METSb
Preoperative comments

















Was the surgery cytoreductive?
Tumor thrombus present?
What is the level of thrombus?
Was cardiac bypass used?
Was lymph node dissection performed?
Was clamping used on the right?
Was ischemia warm or cold?
What was the right side clamp time?
Was early unclamping performed?
Was only the artery clamped?
Was clamping used on the left?
Was ischemia warm or cold?
What was the left side clamp time?
Was early unclamping performed?
Was only the artery clamped?
What was the total clamp time?
Was fluorescence with ICGd used?
What was the time of incision?
What was the time of closure?
Operative comments
Were there any operative complications?
(List of complications)
Specify complication grade
Specify other operative complications
Data entry date:
Data entry person:












Specify other margin location
Side of margin





Extracapsular extension location, specify
Seminal vesicle invasion
Seminal vesicle invasion location
Perineural invasion?
Lymph nodes sampled
Lymph tissue in specimen
Sampled as a group?
Total number positive
Total number sampled
Right lymph nodes positive?





TURBT: Transurethral resection of bladder tumor
b.
MET: Metabolic equivalent of task
c.
ASA score: American Society of Anesthesiologists physical status classification system
d.
ICG: Indocyanine green
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